	ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)	CLUSTER	PREPROCESSED_SENTENCE
S103-BMJ_2010_Apr_29_340_c1640	BMJ_2010_Apr_29_340_c1640	4/2010	S103-BMJ_2010_Apr_29_340_c1640	['overall, epidemiological studies SUPPORT a PROTECTIVE ROLE for Vitamin D in Autoimmune disease, PARTICULARLY in childhood and Adolescence, and Vitamin D supplementation in early Adulthood EFFECTIVELY reduces the risk of multiple sclerosis; THEREFORE, supplementation of adolescents and young Adults COULD BE effectively used for PREVENTION.6the FINDINGS HERE provide the FIRST population BASED evidence beyond month of Birth PATTERNS to INDICATE that Vitamin D supplementation for the PREVENTION of multiple sclerosis MIGHT also NEED to be CONSIDERED during in utero development.14they are CONSISTENT with a multi-hit causal cascade for multiple sclerosis, with PUTATIVE adverse environmental FACTORS, such as low Vitamin D concentrations, acting at more than one stage of Life.53\n\nwhat is already known on this topic\nin the northern hemisphere, there are more cases of multiple sclerosis in People Born in may and fewer in those Born in november\nmaternal exposure to ambient ultraviolet radiation in Pregnancy can be used as an instrumental variable for Vitamin D status during Pregnancy\nlow Vitamin D concentrations HAVE BEEN ASSOCIATED with a higher risk of multiple sclerosis\n\nwhat THIS STUDY adds\nin australia there is a reciprocal PATTERN of month of Birth and risk of multiple sclerosis, with a higher risk for those Born in november-december compared with may-june\nthis PATTERN was accounted FOR by maternal exposure to ambient ultraviolet radiation in the first trimester\nlow maternal exposure to Ultraviolet Radiation in the first trimester was inversely RELATED to risk of multiple sclerosis in the offspring after adjustment for either month of Birth or place of Birth\n\npubmed central:']	[('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 54), ('IMPORTANT_CONSIDERATION', 96), ('IMPORTANT_CONSIDERATION', 188), ('PROBABLE_UNDERSTANDING', 240), ('INCOMPLETE_EVIDENCE', 299), ('SUPERFICIAL_RELATIONSHIP', 329), ('INCOMPLETE_EVIDENCE', 345), ('QUESTION_ANSWERED_BY_THIS_WORK', 354), ('INCOMPLETE_EVIDENCE', 371), ('QUESTION_ANSWERED_BY_THIS_WORK', 388), ('SUPERFICIAL_RELATIONSHIP', 425), ('INCOMPLETE_EVIDENCE', 437), ('SUPERFICIAL_RELATIONSHIP', 485), ('INCOMPLETE_EVIDENCE', 518), ('FUTURE_WORK', 529), ('IMPORTANT_CONSIDERATION', 529), ('FUTURE_WORK', 540), ('IMPORTANT_CONSIDERATION', 540), ('INCOMPLETE_EVIDENCE', 590), ('SUPERFICIAL_RELATIONSHIP', 590), ('PROBABLE_UNDERSTANDING', 662), ('SUPERFICIAL_RELATIONSHIP', 693), ('INCOMPLETE_EVIDENCE', 1118), ('SUPERFICIAL_RELATIONSHIP', 1128), ('QUESTION_ANSWERED_BY_THIS_WORK', 1186), ('SUPERFICIAL_RELATIONSHIP', 1237), ('SUPERFICIAL_RELATIONSHIP', 1378), ('QUESTION_ANSWERED_BY_THIS_WORK', 1400), ('SUPERFICIAL_RELATIONSHIP', 1565)]	31	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 76, 'autoimmune'), ('GO_0048848', 'neurohypophysis morphogenesis', 126, 'adolescence'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('UBERON_0000113', 'post-juvenile adult stage', 178, 'adulthood'), ('UBERON_0007023', 'adult organism', 292, 'adults'), ('GO_0007567', 'parturition', 419, 'birth'), ('CHEBI_27300', 'vitamin D', 451, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 714, 'vitamin D'), ('UBERON_0000104', 'life cycle', 773, 'life'), ('NCBITaxon_10088', 'Mus <genus>', 892, 'people'), ('GO_0007567', 'parturition', 899, 'born'), ('GO_0007567', 'parturition', 930, 'born'), ('GO_0007565', 'female pregnancy', 1001, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1055, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1079, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1093, 'vitamin D'), ('GO_0007567', 'parturition', 1257, 'birth'), ('GO_0007567', 'parturition', 1324, 'born'), ('CHEBI_52927', 'To-Pro-1(2+)', 1506, 'ultraviolet radiation'), ('GO_0007567', 'parturition', 1657, 'birth'), ('GO_0007567', 'parturition', 1675, 'birth')]	0	['overall, epidemiological   disease, childhood adolescence,  supplementation adulthood reduces sclerosis; therefore, supplementation adolescents young adults prevention.6the month birth  supplementation sclerosis utero development.14they multi-hit causal cascade sclerosis, environmental factors,  concentrations, life.53\n\nwhat topic\nin northern hemisphere, cases sclerosis people born born november\nmaternal exposure ambient ultraviolet radiation pregnancy  status pregnancy\nlow  concentrations higher sclerosis\n\nwhat adds\nin australia reciprocal month birth sclerosis, higher born november-december may-june\nthis maternal exposure ambient ultraviolet radiation trimester\nlow maternal exposure ultraviolet radiation trimester sclerosis offspring adjustment place birth\n\npubmed central:']
S8-PMC2685863	PMC2685863	5/2009	S8-PMC2685863	['the next step is determining HOW Vitamin D and Hla-Drb1*15 MIGHT INTERACT to Modulate the Autoimmune nature of ms. epidemiologic and Animal studies of ms POINT TO involvement of the Thymus Gland early in development.']	[('EXPLICIT_QUESTION', 29), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 65), ('INCOMPLETE_EVIDENCE', 154)]	4	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('PR_000002011', 'MHC class I histocompatibility antigen C alpha chain', 47, 'HLA-DRB1'), ('GO_0065007', 'biological regulation', 77, 'modulate'), ('UBERON_0001442', 'skeleton of manus', 90, 'autoimmune'), ('NCBITaxon_33208', 'Metazoa', 133, 'animal'), ('UBERON_0002370', 'thymus', 182, 'thymus gland')]	0	[' hla-drb1*15  nature ms. epidemiologic animal ms thymus gland development.']
S12-PMC2685863	PMC2685863	5/2009	S12-PMC2685863	['the researchers REASON that a lack of Vitamin D in the Thymus in early Life COULD limit this process, THUS enabling “self-directed” T Cells to survive and trigger an Autoimmune response to the Myelin Sheath on Nerve Fibers—a classic feature of ms.']	[('PROBABLE_UNDERSTANDING', 16), ('INCOMPLETE_EVIDENCE', 76), ('PROBABLE_UNDERSTANDING', 102)]	3	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0002370', 'thymus', 55, 'thymus'), ('UBERON_0000104', 'life cycle', 71, 'life'), ('CL_0000084', 'T cell', 132, 'T cells'), ('UBERON_0001442', 'skeleton of manus', 166, 'autoimmune'), ('UBERON_0000347', 'entire myelin sheath', 193, 'myelin sheath'), ('UBERON_0006134', 'nerve fiber', 210, 'nerve fibers')]	0	[' thymus life process, enabling “self-directed” cells survive  response myelin sheath nerve fibers—a ms.']
S10-PMC3075531	PMC3075531	7/2010	S10-PMC3075531	['introduction\nmultiple sclerosis (ms) is a chronic PROBABLY with Autoimmune basis and UNCERTAIN etiology characterized by Demyelinative and inflammatory physiopathology causing Axonal damages.12this disease AFFECTS females more than males with ordinary 10 years Relapsing-remitting course and secondary progressive phase.2on histological basis, T Helper Cells type 1 (th1) is the MOST RESPONSIBLE cause for pathologies SEEN in ms.1–3there are multiple RISK FACTORS for ms in a COMPLEX RELATIONSHIP with each other from Genetic ones to environmental FACTORS BUT exact mechanism leading to ms has REMAINED UNCLEAR yet.45from GUESSED environmental RISK FACTORS for ms, past infection with Ebv, smoking and low Serum level of Vitamin D are more favorable.67the MOST IMPORTANT Vitamin in calcium and Phosphor Homeostasis is Vitamin D. this Vitamin has PROPOSED POTENTIAL power for Modulating Immune System.48this is achieved via enhancing the Phagocytic function of Monocytes9And decreasing the secretion of Il-6, Il-12, Tnf-Α and Pge2 by Monocytes.10also, immature or semi mature Apc’S cannot mature in presence of 1,25 (Oh)2D.8MANY STUDIES SHOWED a ROLE of paracrine function and Nerve Growth Factor Synthesis Of Vitamin D in Cns and also, SHOWED that deficiency of this Vitamin in Pregnancy Period CAN cause Neural System disorder in Animal cases.811–14then, Vitamin D has a near RELATION with ms and the results of DIFFERENT studies can be summarized as follows: first, the EFFECT of latitude via exposure to sun light and Serum level of Vitamin D on ms prevalence, that increases with distance from equator, with ONLY one EXCEPTION in norway.23815second, vander et al.']	[('PROBABLE_UNDERSTANDING', 50), ('FULL_UNKNOWN', 85), ('SUPERFICIAL_RELATIONSHIP', 206), ('PROBABLE_UNDERSTANDING', 379), ('PROBABLE_UNDERSTANDING', 384), ('INCOMPLETE_EVIDENCE', 418), ('SUPERFICIAL_RELATIONSHIP', 451), ('DIFFICULT_TASK', 476), ('SUPERFICIAL_RELATIONSHIP', 484), ('SUPERFICIAL_RELATIONSHIP', 548), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 556), ('INCOMPLETE_EVIDENCE', 594), ('FULL_UNKNOWN', 603), ('INCOMPLETE_EVIDENCE', 622), ('SUPERFICIAL_RELATIONSHIP', 644), ('PROBABLE_UNDERSTANDING', 756), ('IMPORTANT_CONSIDERATION', 761), ('INCOMPLETE_EVIDENCE', 846), ('INCOMPLETE_EVIDENCE', 855), ('INCOMPLETE_EVIDENCE', 1123), ('INCOMPLETE_EVIDENCE', 1136), ('SUPERFICIAL_RELATIONSHIP', 1145), ('INCOMPLETE_EVIDENCE', 1236), ('INCOMPLETE_EVIDENCE', 1295), ('SUPERFICIAL_RELATIONSHIP', 1377), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1413), ('SUPERFICIAL_RELATIONSHIP', 1472), ('ANOMALY_CURIOUS_FINDING', 1612), ('ANOMALY_CURIOUS_FINDING', 1621)]	29	[('UBERON_0001442', 'skeleton of manus', 64, 'autoimmune'), ('GO_0006188', 'IMP biosynthetic process', 121, 'demyelinative'), ('GO_0030424', 'axon', 176, 'axonal'), ('GO_0065007', 'biological regulation', 261, 'relapsing'), ('CL_0000545', 'T-helper 1 cell', 344, 'T helper cells'), ('SO_0000704', 'gene', 518, 'genetic'), ('NCBITaxon_10088', 'Mus <genus>', 685, 'EBV'), ('UBERON_0001977', 'blood serum', 706, 'serum'), ('CHEBI_27300', 'vitamin D', 721, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 771, 'vitamin'), ('CHEBI_30215', 'muonide', 794, 'phosphor'), ('GO_0042592', 'homeostatic process', 803, 'homeostasis'), ('CHEBI_27300', 'vitamin D', 818, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 834, 'vitamin'), ('GO_0065007', 'biological regulation', 875, 'modulating'), ('UBERON_0002405', 'immune system', 886, 'immune system'), ('GO_0006909', 'phagocytosis', 937, 'phagocytic'), ('CL_0002198', 'oncocyte', 960, 'monocytes9and'), ('PR_000001470', 'interleukin-28B', 1002, 'IL-6'), ('PR_000001470', 'interleukin-28B', 1008, 'IL-12'), ('PR_000000134', 'tumor necrosis factor alpha', 1015, 'TNF-α'), ('PR_000012560', 'peroxisomal membrane protein PEX14', 1025, 'PGE2'), ('CL_0000576', 'monocyte', 1033, 'monocytes'), ('PR_000004122', 'adenomatous polyposis coli protein', 1075, 'APC'), ('PR_000011000', 'N-alpha-acetyltransferase 60', 1079, 's'), ('CHEBI_82784', 'PVP38-Ag NP', 1110, '1,25 (OH)2D'), ('UBERON_0001021', 'nerve', 1176, 'nerve'), ('GO_0040007', 'growth', 1182, 'growth factor'), ('GO_0030474', 'spindle pole body duplication', 1196, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 1209, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 1222, 'CNS'), ('CHEBI_33229', 'vitamin (role)', 1267, 'vitamin'), ('GO_0007565', 'female pregnancy', 1278, 'pregnancy'), ('UBERON_0018298', 'stylocone', 1278, 'pregnancy period'), ('UBERON_0023879', 'neural system', 1305, 'neural system'), ('NCBITaxon_33208', 'Metazoa', 1331, 'animal'), ('CHEBI_27300', 'vitamin D', 1356, 'vitamin D'), ('UBERON_0001977', 'blood serum', 1521, 'serum'), ('CHEBI_27300', 'vitamin D', 1536, 'vitamin D')]	0	['introduction\nmultiple sclerosis (ms) chronic  etiology demyelinative inflammatory physiopathology axonal damages.12this disease females males ordinary 10 relapsing-remitting course secondary progressive phase.2on histological basis, helper cells type (th1) pathologies ms.1–3there ms genetic ones environmental exact ms yet.45from environmental ms, infection ebv, smoking serum  favorable.67the vitamin calcium phosphor homeostasis . vitamin immune system.48this achieved via phagocytic monocytes9and decreasing secretion il-6, il-12, tnf-α pge2 monocytes.10also, immature semi mature apc’s mature presence 1,25 (oh)2d.8many paracrine nerve synthesis  cns also, vitamin pregnancy period neural system disorder animal cases.811–14then,  ms results follows: first, latitude via exposure sun serum  ms prevalence, distance equator, norway.23815second, vander et al.']
S11-PMC3075531	PMC3075531	7/2010	S11-PMC3075531	['SHOWED that sun exposure in Childhood period PREVENTS from ms.16third, it SEEMS low risk of ms in white population is ASSOCIATED with high Serum level of vitamin d or high oral Intake via supplements or oily fish in SOME STUDIES.217–19fourth, it HAVE BEEN SHOWN that Vitamin D CAN be a PROTECTIVE agent against experimental Autoimmune encephalitis in Mice (like ms in Humans).48finally, some scientists administered 100-1700 iu/day Vitamin D supplements in ms patients and OBSERVED the reduction of relapses.20–22the CANDIDATE for estimating Serum level of Vitamin D is 25-Hydroxy Vitamin D, BECAUSE of its prolonged half-Life.823–25it is used to assess an Individual’s overall Vitamin D nutritional status, BECAUSE its formation, UNLIKE that of 1, 25-Dihydroxy Vitamin D, is not tightly Regulated and it has a relatively long half-life (20-60 days).']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 45), ('ANOMALY_CURIOUS_FINDING', 74), ('SUPERFICIAL_RELATIONSHIP', 118), ('INCOMPLETE_EVIDENCE', 216), ('INCOMPLETE_EVIDENCE', 246), ('INCOMPLETE_EVIDENCE', 277), ('SUPERFICIAL_RELATIONSHIP', 286), ('INCOMPLETE_EVIDENCE', 473), ('INCOMPLETE_EVIDENCE', 517), ('PROBABLE_UNDERSTANDING', 592), ('PROBABLE_UNDERSTANDING', 708), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 731)]	13	[('UBERON_0013628', 'pollical pad', 28, 'childhood'), ('UBERON_0001977', 'blood serum', 139, 'serum'), ('GO_0007631', 'feeding behavior', 177, 'intake'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 324, 'autoimmune'), ('NCBITaxon_10088', 'Mus <genus>', 351, 'mice'), ('NCBITaxon_9606', 'Homo sapiens', 368, 'humans'), ('CHEBI_27300', 'vitamin D', 432, 'vitamin D'), ('UBERON_0001977', 'blood serum', 542, 'serum'), ('CHEBI_27300', 'vitamin D', 557, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 570, '25-hydroxy vitamin D'), ('UBERON_0000104', 'life cycle', 622, 'life'), ('NCBITaxon_1', 'root', 657, 'individual'), ('CHEBI_27300', 'vitamin D', 678, 'vitamin D'), ('CHEBI_43176', 'hydroxy group', 752, 'dihydroxy'), ('CHEBI_27300', 'vitamin D', 762, 'vitamin D'), ('GO_0065007', 'biological regulation', 788, 'regulated')]	0	['showed sun exposure childhood period ms.16third, ms white population serum vitamin oral intake via supplements oily fish studies.217–19fourth,  agent  encephalitis mice (like ms humans).48finally, scientists administered 100-1700 iu/day  supplements ms patients reduction relapses.20–22the serum  25-hydroxy vitamin d, prolonged half-life.823–25it individual’s  nutritional status, formation, 1, 25-dihydroxy tightly half-life (20-60 days).']
S12-PMC3075531	PMC3075531	7/2010	S12-PMC3075531	['there are DIFFERENCES in OPTIMAL level of 25-Hydroxy Vitamin D BUT nowadays internationally ACCEPTED normal range is between 75 nmol/l and 200 nmol/l, and we CONSIDER Serum level below 75 nmol/l and below 2 nmol/l as insufficiency and deficiency, respectively.42325even it SEEMS to achieve the prevention of Autoimmune diseases, the Serum level of Vitamin D MUST BE higher than the level required to reduce osteoporosis (higher than 75 nmol/l).4in attention to high prevalence of ms in iran and especially in isfahan which is ABOUT 43.5/100,0002627and GIVEN that iran is located in an latitude of 32° 50’ and longitude of 51° 43’ with enough sun exposure and BECAUSE nobody INVESTIGATED the RELATIONSHIP between Vitamin D, AS an environmental agent, and ms disease in iran before, we DECIDED to compare the Serum level of 25-Hydroxy Vitamin D in ms patients and healthy control group in isfahan region.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('IMPORTANT_CONSIDERATION', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 63), ('INCOMPLETE_EVIDENCE', 92), ('INCOMPLETE_EVIDENCE', 158), ('ANOMALY_CURIOUS_FINDING', 273), ('IMPORTANT_CONSIDERATION', 358), ('INCOMPLETE_EVIDENCE', 526), ('PROBABLE_UNDERSTANDING', 552), ('PROBABLE_UNDERSTANDING', 659), ('QUESTION_ANSWERED_BY_THIS_WORK', 674), ('SUPERFICIAL_RELATIONSHIP', 691), ('PROBABLE_UNDERSTANDING', 723), ('QUESTION_ANSWERED_BY_THIS_WORK', 784)]	14	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 42, '25-hydroxy vitamin D'), ('UBERON_0001977', 'blood serum', 167, 'serum'), ('UBERON_0001442', 'skeleton of manus', 308, 'autoimmune'), ('UBERON_0001977', 'blood serum', 333, 'serum'), ('CHEBI_27300', 'vitamin D', 348, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 712, 'vitamin D'), ('UBERON_0001977', 'blood serum', 807, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 822, '25-hydroxy vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 841, 'D')]	0	['25-hydroxy vitamin nowadays internationally normal 75 nmol/l 200 nmol/l, serum 75 nmol/l 2 nmol/l deficiency, respectively.42325even achieve  diseases, serum  higher osteoporosis (higher 75 nmol/l).4in ms iran isfahan 43.5/100,0002627and iran located latitude 32° 50’ longitude 51° 43’ sun exposure nobody environmental agent, ms disease iran before, serum 25-hydroxy vitamin ms patients healthy isfahan region.']
S9-PMC3277098	PMC3277098	12/2011	S9-PMC3277098	['aside from Skeletal health, Vitamin D HAS BEEN ASSOCIATED with various cancers and Autoimmune disorders [1] with EVIDENCE FOR a ROLE in development and maintenance of Lung structure and function [3,4,5].']	[('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 113), ('SUPERFICIAL_RELATIONSHIP', 128)]	4	[('UBERON_0004288', 'skeleton', 11, 'skeletal'), ('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 83, 'autoimmune'), ('UBERON_0002048', 'lung', 167, 'lung')]	0	['aside skeletal health,  cancers  disorders [1] maintenance lung structure [3,4,5].']
S47-PMC3277098	PMC3277098	12/2011	S47-PMC3277098	['this MAY BE one POSSIBLE EXPLANATION for the epidemiological LINKS between both Autoimmune disease and allergy with Vitamin D deficiency [31].']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 16), ('PROBABLE_UNDERSTANDING', 25), ('SUPERFICIAL_RELATIONSHIP', 61)]	4	[('UBERON_0001442', 'skeleton of manus', 80, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]	0	['epidemiological  disease allergy  [31].']
S78-PMC3347028	PMC3347028	3/2012	S78-PMC3347028	['these in vitro FINDINGS HELP to EXPLAIN the significant ASSOCIATION between Vitamin D deficiency and Autoimmune diseases, such as systemic lupus erythematosus [25], multiple sclerosis [26,27,28,29,30,31,32,33,34,35], rheumatoid arthritis [31,36,37], diabetes—both types 1 [31,38,39,40,41,42] and 2 [43,44,45], and certain cancers, such as Colon [46,47,48,49], Breast [50,51,52,53,54,55], and Prostate [55,56,57,58,59].']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 24), ('PROBABLE_UNDERSTANDING', 32), ('SUPERFICIAL_RELATIONSHIP', 56)]	4	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 101, 'autoimmune'), ('UBERON_0001155', 'colon', 339, 'colon'), ('UBERON_0000310', 'breast', 360, 'breast'), ('UBERON_0002367', 'prostate gland', 392, 'prostate')]	0	['  diseases, systemic lupus erythematosus [25], sclerosis [26,27,28,29,30,31,32,33,34,35], rheumatoid arthritis [31,36,37], diabetes—both [31,38,39,40,41,42] 2 [43,44,45], cancers, colon [46,47,48,49], breast [50,51,52,53,54,55], prostate [55,56,57,58,59].']
S155-PMC3347028	PMC3347028	3/2012	S155-PMC3347028	['mcgrath and others continue to investigate WHETHER there are lasting EFFECTS of fetal and early infancy Vitamin D deficiency on later Adult disease processes such as Anatomical changes of the Brain, schizophrenia, multiple sclerosis, certain cancers, Cardiovascular disease, and various other Autoimmune diseases such as diabetes and lupus [106,107,108,109,110,111,112,113,114,115,116,117,118,119,120,121].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 43), ('SUPERFICIAL_RELATIONSHIP', 69)]	2	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('UBERON_0007023', 'adult organism', 134, 'adult'), ('UBERON_0001062', 'anatomical entity', 166, 'anatomical'), ('UBERON_0000955', 'brain', 192, 'brain'), ('UBERON_0004535', 'cardiovascular system', 251, 'cardiovascular'), ('UBERON_0001442', 'skeleton of manus', 293, 'autoimmune')]	0	['mcgrath lasting fetal infancy  adult disease processes anatomical changes brain, schizophrenia, sclerosis, cancers, cardiovascular disease,  diseases diabetes lupus [106,107,108,109,110,111,112,113,114,115,116,117,118,119,120,121].']
S16-PMC3356951	PMC3356951	4/2012	S16-PMC3356951	['[5] emerging RESEARCH SUPPORTS the POSSIBLE ROLE of Vitamin D against cancer, Heart disease, fractures and falls, Autoimmune diseases, influenza, type-2 diabetes, and depression.']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 44)]	4	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('UBERON_0000948', 'heart', 78, 'heart'), ('UBERON_0001442', 'skeleton of manus', 114, 'autoimmune')]	0	['[5]  cancer, disease, fractures falls,  diseases, influenza, type-2 diabetes, depression.']
S16-PMC3427250	PMC3427250	8/2012	S16-PMC3427250	['adequate Vitamin D intake is ASSOCIATED with a lower risk of cancer[7],[8],[9],[10],[11], Cardiovascular diseases[12], Autoimmune diseases[13], Neurological disorders[14]and diabetes[15].']	[('SUPERFICIAL_RELATIONSHIP', 29)]	1	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 90, 'cardiovascular'), ('UBERON_0001442', 'skeleton of manus', 119, 'autoimmune'), ('UBERON_0001016', 'nervous system', 144, 'neurological')]	0	['adequate  intake cancer[7],[8],[9],[10],[11], cardiovascular diseases[12],  diseases[13], neurological disorders[14]and diabetes[15].']
S0-PMC3476426	PMC3476426	8/2012	S0-PMC3476426	['reduced Serum concentrations of 25-Hydroxy Vitamin D in children with autism: RELATION to autoimmunity\n\nabstract\n\nbackground\naside from the Skeletal health affection, Vitamin D deficiency has BEEN IMPLICATED as a POTENTIAL environmental FACTOR triggering for SOME Autoimmune disorders.']	[('SUPERFICIAL_RELATIONSHIP', 78), ('ANOMALY_CURIOUS_FINDING', 192), ('SUPERFICIAL_RELATIONSHIP', 197), ('INCOMPLETE_EVIDENCE', 213), ('SUPERFICIAL_RELATIONSHIP', 237), ('INCOMPLETE_EVIDENCE', 259)]	6	[('UBERON_0001977', 'blood serum', 8, 'serum'), ('CHEBI_43141', '3-hydroxypropoxy group', 32, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('UBERON_0004288', 'skeleton', 140, 'skeletal'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 264, 'autoimmune')]	0	['reduced serum concentrations 25-hydroxy  children autism: autoimmunity\n\nabstract\n\nbackground\naside skeletal affection,  environmental  disorders.']
S22-PMC3476426	PMC3476426	8/2012	S22-PMC3476426	['RECENTLY, Vitamin D deficiency HAS BEEN IMPLICATED as a POTENTIAL environmental FACTOR triggering SOME Autoimmune disorders, including multiple sclerosis (ms) and systemic lupus erythematosus (sle) [5-7].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 40), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 98)]	6	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 103, 'autoimmune')]	0	['recently,  environmental  disorders, sclerosis (ms) systemic lupus erythematosus (sle) [5-7].']
S91-PMC3476426	PMC3476426	8/2012	S91-PMC3476426	['RECENTLY, Vitamin D deficiency HAS BEEN IMPLICATED as a POTENTIAL environmental FACTOR triggering SOME Autoimmune disorders [5,6].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 40), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 98)]	6	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 103, 'autoimmune')]	0	['recently,  environmental  disorders [5,6].']
S128-PMC3476426	PMC3476426	8/2012	S128-PMC3476426	['Vitamin D deficiency HAS BEEN IMPLICATED as a POTENTIAL environmental FACTOR triggering SOME Autoimmune disorders SUGGESTING that Vitamin D MIGHT play a ROLE in Regulating auto-Antibody production [5,6].']	[('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 30), ('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 70), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 140), ('SUPERFICIAL_RELATIONSHIP', 153)]	8	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0001442', 'skeleton of manus', 93, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0065007', 'biological regulation', 161, 'regulating'), ('GO_0042571', 'immunoglobulin complex, circulating', 177, 'antibody')]	0	['vitamin environmental  disorders  play auto-antibody production [5,6].']
S145-PMC3476426	PMC3476426	8/2012	S145-PMC3476426	['basic, Genetic, and epidemiological studies INDICATE a POTENTIAL ROLE of Vitamin D in the PREVENTION of Autoimmune diseases, BUT randomized and controlled TRIALS ARE NECESSARY to establish the clinical efficacy of Vitamin D supplementation in ill or at-RISK subjects [48].']	[('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 55), ('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 90), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 125), ('FUTURE_WORK', 155), ('FUTURE_WORK', 166), ('IMPORTANT_CONSIDERATION', 166), ('IMPORTANT_CONSIDERATION', 253)]	9	[('SO_0000704', 'gene', 7, 'genetic'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 104, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D')]	0	['basic, genetic, epidemiological   diseases,  supplementation subjects [48].']
S39-PMC3635901	PMC3635901	4/2013	S39-PMC3635901	['THE NEED to provide Vitamin D supplementation for patients with Autoimmune diseases, including ss, is clear.']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 64, 'autoimmune')]	0	[' supplementation patients  diseases, ss, clear.']
S126-PMC3659910	PMC3659910	1/2013	S126-PMC3659910	['Animal MODELS of Vitamin D deficiency HAVE SHOWN just how IMPORTANT adequate nutritional intakes of Vitamin D are to Skeletal, Cardiovascular, and Neurologic Development in experimental Animals.']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 38), ('IMPORTANT_CONSIDERATION', 58)]	3	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('GO_0001501', 'skeletal system development', 117, 'skeletal ...'), ('UBERON_0001442', 'skeleton of manus', 117, 'skeletal ...'), ('GO_0002026', 'regulation of the force of heart contraction', 127, 'cardiovascular ...'), ('UBERON_0004535', 'cardiovascular system', 127, 'cardiovascular'), ('GO_0007399', 'nervous system development', 147, 'neurologic development'), ('UBERON_0001016', 'nervous system', 147, 'neurologic'), ('NCBITaxon_33208', 'Metazoa', 186, 'animals')]	0	['animal  nutritional intakes  cardiovascular, neurologic animals.']
S20-PMC3672018	PMC3672018	5/2013	S20-PMC3672018	['low Vitamin D during Gestation and in early Life MAY THEREFORE play an IMPORTANT ROLE for susceptibility to bone fragility, obesity and Autoimmune diseases later in Life [6].']	[('INCOMPLETE_EVIDENCE', 49), ('PROBABLE_UNDERSTANDING', 53), ('IMPORTANT_CONSIDERATION', 71), ('SUPERFICIAL_RELATIONSHIP', 81)]	4	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('GO_0007565', 'female pregnancy', 21, 'gestation'), ('UBERON_0000104', 'life cycle', 44, 'life'), ('UBERON_0001442', 'skeleton of manus', 136, 'autoimmune'), ('UBERON_0000104', 'life cycle', 165, 'life')]	0	['low  gestation life play bone fragility, obesity  diseases life [6].']
S42-PMC3672018	PMC3672018	5/2013	S42-PMC3672018	['furthermore, there are studies SHOWING that low fetal Vitamin D MAY lead to persistent changes in the Immune System, THUS POSSIBLY INFLUENCING the risk of developing Autoimmune diseases such as t1d [14,19,20].']	[('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 64), ('PROBABLE_UNDERSTANDING', 117), ('INCOMPLETE_EVIDENCE', 122), ('SUPERFICIAL_RELATIONSHIP', 131)]	5	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('UBERON_0002405', 'immune system', 102, 'immune system'), ('UBERON_0001442', 'skeleton of manus', 166, 'autoimmune')]	0	['furthermore, fetal  changes immune system,  diseases t1d [14,19,20].']
S101-PMC3672018	PMC3672018	5/2013	S101-PMC3672018	['for instance, INFLUENCE of low Vitamin D on obesity and Adipose Tissues MAY BE particularly IMPORTANT for children whose third Gestation periods occur during winter, WHILE INFLUENCE of low Vitamin D on Autoimmune diseases MAY BE particularly IMPORTANT for children whose first Gestational trimester occurs during winter.']	[('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 72), ('IMPORTANT_CONSIDERATION', 92), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 166), ('SUPERFICIAL_RELATIONSHIP', 172), ('INCOMPLETE_EVIDENCE', 222), ('IMPORTANT_CONSIDERATION', 242)]	7	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('UBERON_0001013', 'adipose tissue', 56, 'adipose tissues'), ('GO_0007565', 'female pregnancy', 127, 'gestation'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 202, 'autoimmune'), ('GO_0007565', 'female pregnancy', 277, 'gestational')]	0	['instance,  obesity adipose tissues children whose third gestation periods occur winter,   diseases children whose gestational trimester occurs winter.']
S3-PMC3717170	PMC3717170	5/2013	S3-PMC3717170	['THIS REPORT summarizes RECENT RESEARCH on the ROLES for Vitamin D in cancer, Immunity and Autoimmune diseases, Cardiovascular and Respiratory health, Pregnancy, obesity, Erythropoiesis, diabetes, muscle function, and Aging.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 46)]	3	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0007566', 'embryo implantation', 77, 'immunity'), ('UBERON_0001442', 'skeleton of manus', 90, 'autoimmune'), ('UBERON_0004535', 'cardiovascular system', 111, 'cardiovascular'), ('UBERON_0001004', 'respiratory system', 130, 'respiratory'), ('GO_0007565', 'female pregnancy', 150, 'pregnancy'), ('GO_0030218', 'erythrocyte differentiation', 170, 'erythropoiesis'), ('GO_0007568', 'aging', 217, 'aging')]	0	['summarizes  cancer, immunity  diseases, cardiovascular respiratory health, pregnancy, obesity, erythropoiesis, diabetes, muscle function, aging.']
S20-PMC3717170	PMC3717170	5/2013	S20-PMC3717170	['the mechanism of 1,25(Oh)2D3Suppression of Il-17 was found to be transcriptional and to involve blocking of Nuclear factor for Activated T Cells (Nfat, which is IMPORTANT for T Cell receptor–mediated transcriptional Regulation of Il-17), recruitment of Histone deacetylase to the Il-17 Promoter, and Sequestration of Runt-Related Transcription Factor 1 (runx1) by the vdr.31,25(Oh)2D3Was also FOUND to have a direct EFFECT on the induction of Foxp3, a transcription factor that ASSOCIATES with Nfat and runx1 for transcriptional repression.3THESE results DESCRIBE NOVEL mechanisms and new CONCEPTS with regard to Vitamin D and the Immune System and SUGGEST THERAPEUTIC TARGETS for the Control of Autoimmune diseases.']	[('IMPORTANT_CONSIDERATION', 161), ('ANOMALY_CURIOUS_FINDING', 393), ('SUPERFICIAL_RELATIONSHIP', 416), ('SUPERFICIAL_RELATIONSHIP', 478), ('INCOMPLETE_EVIDENCE', 540), ('INCOMPLETE_EVIDENCE', 555), ('FULL_UNKNOWN', 564), ('INCOMPLETE_EVIDENCE', 589), ('FUTURE_WORK', 649), ('INCOMPLETE_EVIDENCE', 649), ('FUTURE_WORK', 657), ('FUTURE_WORK', 669)]	12	[('CHEBI_42976', 'L-glycero-alpha-D-manno-heptopyranose', 17, '1,25(OH)2D3suppression'), ('PR_000001470', 'interleukin-28B', 43, 'IL-17'), ('GO_0005634', 'nucleus', 108, 'nuclear'), ('CL_0002129', 'regular atrial cardiac myocyte', 127, 'activated T cells'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 146, 'NFAT'), ('CL_0000084', 'T cell', 175, 'T cell'), ('GO_0065007', 'biological regulation', 216, 'regulation'), ('PR_000001470', 'interleukin-28B', 230, 'IL-17'), ('CHEBI_15358', 'histone', 253, 'histone'), ('PR_000043452', 'core histone', 253, 'histone'), ('PR_000001470', 'interleukin-28B', 280, 'IL-17'), ('SO_0000167', 'promoter', 286, 'promoter'), ('GO_0051235', 'maintenance of location', 300, 'sequestration'), ('PR_000014373', 'retinoic acid receptor RXR-beta', 317, 'Runt-related transcription factor 1'), ('CHEBI_73386', 'Ala-Val-Asp-Ser', 375, '25(OH)2D3was'), ('PR_000007655', 'GSK-3-binding protein FRAT2', 443, 'Foxp3'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 494, 'NFAT'), ('CHEBI_27300', 'vitamin D', 613, 'vitamin D'), ('UBERON_0002405', 'immune system', 631, 'immune system'), ('GO_0065007', 'biological regulation', 685, 'control'), ('UBERON_0001442', 'skeleton of manus', 696, 'autoimmune')]	0	['1,25(oh)2d3suppression il-17 transcriptional blocking nuclear activated cells (nfat, cell receptor–mediated transcriptional il-17), recruitment histone deacetylase il-17 promoter, sequestration runt-related transcription (runx1) vdr.31,25(oh)2d3was induction foxp3, transcription nfat runx1 transcriptional repression.3these results mechanisms regard  immune system  diseases.']
S44-PMC3717170	PMC3717170	5/2013	S44-PMC3717170	['as with antibacterial Responses to infection, it HAS BEEN PROPOSED that Adaptive Immune Responses MAY BE compromised in patients with low Serum concentrations of 25(Oh)D3, and ASSOCIATION studies HAVE SHOWN LINKS between Autoimmune disease and Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 49), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 98), ('SUPERFICIAL_RELATIONSHIP', 176), ('INCOMPLETE_EVIDENCE', 196), ('SUPERFICIAL_RELATIONSHIP', 207)]	6	[('GO_0060033', 'anatomical structure regression', 22, 'responses'), ('GO_0051866', 'general adaptation syndrome', 72, 'adaptive immune responses'), ('UBERON_0002405', 'immune system', 81, 'immune'), ('UBERON_0001977', 'blood serum', 138, 'serum'), ('CHEBI_62946', 'ammonium sulfate', 162, '25(OH)D3'), ('UBERON_0001442', 'skeleton of manus', 221, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 244, 'vitamin D')]	0	['antibacterial responses infection, adaptive immune responses patients serum concentrations 25(oh)d3,  disease  deficiency.']
S179-PMC3717170	PMC3717170	5/2013	S179-PMC3717170	['Vitamin D AFFECTS several pathways RELATED to inflammation and Cell Proliferation, including inhibition of aromatase (conversion from Testosterone to Estrogens), Cox2, prostaglandin receptor, Nf-κb, Hif-1 and Vegf, and stimulation of Igfbp-3 and E-Cadherin.52in addition, poor Vitamin D status is a RISK factor for several Autoimmune diseases, CONFIRMING the ROLE of this Vitamin in Immune function.']	[('SUPERFICIAL_RELATIONSHIP', 10), ('SUPERFICIAL_RELATIONSHIP', 35), ('SUPERFICIAL_RELATIONSHIP', 299), ('PROBABLE_UNDERSTANDING', 344), ('SUPERFICIAL_RELATIONSHIP', 359)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0008283', 'cell proliferation', 63, 'cell proliferation'), ('CHEBI_17347', 'testosterone', 134, 'testosterone'), ('CHEBI_50114', 'estrogen', 150, 'estrogens'), ('PR_000005773', 'cytochrome c oxidase copper chaperone', 162, 'COX2'), ('GO_0005883', 'neurofilament', 192, 'NF'), ('PR_000008539', 'protein-cysteine N-palmitoyltransferase HHAT-like protein', 199, 'HIF-1'), ('PR_000017279', 'testis-specific basic protein Y 1', 209, 'VEGF'), ('PR_000008940', 'intraflagellar transport protein 88', 234, 'IGFBP-3'), ('PR_000001447', 'cadherin-1', 246, 'E-cadherin'), ('CHEBI_27300', 'vitamin D', 277, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 323, 'autoimmune'), ('CHEBI_33229', 'vitamin (role)', 372, 'vitamin'), ('UBERON_0002405', 'immune system', 383, 'immune')]	0	['vitamin inflammation cell proliferation, inhibition aromatase (conversion testosterone estrogens), cox2, prostaglandin receptor, nf-κb, hif-1 vegf, stimulation igfbp-3 e-cadherin.52in addition,  status  diseases, vitamin immune function.']
S36-PMC3760821	PMC3760821	9/2013	S36-PMC3760821	['additionally, there is EMERGING EVIDENCE DEMONSTRATING an ASSOCIATION between foetal and early childhood Vitamin D deficiency and later Adult disease processes, such as multiple sclerosis, cardiovascular disease, schizophrenia, certain cancers and other Autoimmune diseases such as t1dm and lupus[16].']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 58)]	3	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('UBERON_0007023', 'adult organism', 136, 'adult'), ('UBERON_0001442', 'skeleton of manus', 254, 'autoimmune')]	0	['additionally, foetal childhood  adult disease processes, sclerosis, cardiovascular disease, schizophrenia, cancers  diseases t1dm lupus[16].']
S21-PMC3827489	PMC3827489	10/2013	S21-PMC3827489	['the wide variety of nonskeletal diseases in which Vitamin D is IMPORTANT include Cardiovascular diseases3), obesity4), Metabolic syndrome5), Insulin resistance6), infection7), allergy8,9), some forms of cancers10-12), and Autoimmune diseases13).']	[('IMPORTANT_CONSIDERATION', 63)]	1	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 81, 'cardiovascular'), ('GO_0008152', 'metabolic process', 119, 'metabolic'), ('PR_000045358', 'insulin family protein', 141, 'insulin'), ('UBERON_0001442', 'skeleton of manus', 222, 'autoimmune')]	0	['nonskeletal diseases  cardiovascular diseases3), obesity4), metabolic syndrome5), insulin resistance6), infection7), allergy8,9), forms cancers10-12),  diseases13).']
S25-PMC3873449	PMC3873449	12/2013	S25-PMC3873449	['there is LITTLE EVIDENCE concerning the ROLE of maternal Vitamin D in Pregnancy in their child Autoimmune diseases.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 40)]	2	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('UBERON_0001442', 'skeleton of manus', 95, 'autoimmune')]	0	['maternal  pregnancy child  diseases.']
S274-PMC4045304	PMC4045304	2/2014	S274-PMC4045304	['PLAUSIBLE mechanisms HAVE BEEN put FORWARD to EXPLAIN the palliative ROLE of Vitamin D in children with autism via Dna Repair, anti-inflammatory actions, Autoimmune activities, and increase in Regulatory T Cells or stimulation antioxidant pathways.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('FUTURE_WORK', 35), ('PROBABLE_UNDERSTANDING', 46), ('SUPERFICIAL_RELATIONSHIP', 69)]	5	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('GO_0006281', 'DNA repair', 115, 'DNA repair'), ('UBERON_0001442', 'skeleton of manus', 154, 'autoimmune'), ('CL_0000815', 'regulatory T cell', 193, 'regulatory T cells'), ('GO_0065007', 'biological regulation', 193, 'regulatory')]	0	['plausible mechanisms palliative  children autism via dna repair, anti-inflammatory actions,  activities, increase cells stimulation antioxidant pathways.']
S39-PMC4106226	PMC4106226	7/2014	S39-PMC4106226	['RECENT STUDIES SUGGEST that Vitamin D deficiency MAY increase the RISK of developing Autoimmune diseases including type 1 diabetes (t1dm), by Modulating the Immune and inflammatory reactions.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 49), ('IMPORTANT_CONSIDERATION', 66)]	4	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 85, 'autoimmune'), ('GO_0065007', 'biological regulation', 142, 'modulating'), ('UBERON_0002405', 'immune system', 157, 'immune')]	0	['recent  increase  diseases type diabetes (t1dm), immune inflammatory reactions.']
S12-PMC4169453	PMC4169453	9/2014	S12-PMC4169453	['trial registration\nclinicaltrials.govnct01506557\n\nintroduction\nGROWING EVIDENCE SUGGESTS that Vitamin D deficiency has a negative IMPACT on the Skeletal System and MAY BE a POTENTIAL RISK FACTOR for a wide range of diseases, including cancer, Cardiovascular disease, hypertension, diabetes, Autoimmune diseases, and allergies[1].']	[('INCOMPLETE_EVIDENCE', 63), ('INCOMPLETE_EVIDENCE', 80), ('SUPERFICIAL_RELATIONSHIP', 130), ('INCOMPLETE_EVIDENCE', 164), ('INCOMPLETE_EVIDENCE', 173), ('SUPERFICIAL_RELATIONSHIP', 183)]	6	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('UBERON_0001434', 'skeletal system', 144, 'skeletal system'), ('UBERON_0004535', 'cardiovascular system', 243, 'cardiovascular'), ('UBERON_0001442', 'skeleton of manus', 291, 'autoimmune')]	0	['trial registration\nclinicaltrials.govnct01506557\n\nintroduction\ngrowing  skeletal system diseases, cancer, cardiovascular disease, hypertension, diabetes,  diseases, allergies[1].']
S2-PMC4251419	PMC4251419	12/2014	S2-PMC4251419	['there are PLAUSIBLE pathways whereby Vitamin D deficiency CAN impair Immune function, resulting in both overactivity and increased risk of Autoimmune disease, as well as Immune suppression with poorer resistance to infection.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 58)]	2	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('UBERON_0002405', 'immune system', 69, 'immune'), ('UBERON_0001442', 'skeleton of manus', 139, 'autoimmune'), ('UBERON_0002405', 'immune system', 170, 'immune')]	0	['whereby  immune function, resulting overactivity  disease, immune suppression resistance infection.']
S15-PMC4251419	PMC4251419	12/2014	S15-PMC4251419	['both uvr and Vitamin D (in its active form 1,25(Oh)2D, seefigure 1) have immunomodulatory EFFECTS [8] that provide a PLAUSIBLE mechanism whereby higher levels COULD decrease the risk of Autoimmune diseases (see section on mechanisms, below) and, through the same pathways, COULD impair the Immune Response to vaccination or infection [9,10].']	[('SUPERFICIAL_RELATIONSHIP', 90), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 159), ('INCOMPLETE_EVIDENCE', 273)]	4	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('CHEBI_17996', 'chloride', 44, ','), ('CHEBI_66212', '5,7,3*,4*-tetrahydroxy-2*-(3,3-dimethylallyl)isoflavone', 45, '25(OH)2D'), ('UBERON_0001442', 'skeleton of manus', 186, 'autoimmune'), ('GO_0006955', 'immune response', 290, 'immune response'), ('UBERON_0002405', 'immune system', 290, 'immune')]	0	['uvr  (in form 1,25(oh)2d, seefigure 1) immunomodulatory [8] whereby higher levels decrease  diseases (see section mechanisms, below) and, pathways, immune response vaccination infection [9,10].']
S22-PMC4251419	PMC4251419	12/2014	S22-PMC4251419	['in case-control studies, participants with one of these Autoimmune diseases TEND to report lower past sun exposure, and/or have lower Vitamin D status (measured as the Blood concentration of the intermediary Metabolite, 25(Oh)D, seefigure 1), than healthy controls (see for example recent reviews [12,13]).']	[('SUPERFICIAL_RELATIONSHIP', 76)]	1	[('UBERON_0001442', 'skeleton of manus', 56, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('UBERON_0000178', 'blood', 168, 'blood'), ('CHEBI_39382', 'flufenoxuron', 208, 'metabolite'), ('CHEBI_71657', 'versiconol acetate', 220, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 220, '25(OH)D')]	0	['case-control studies, participants  diseases sun exposure, and/or  status (measured blood concentration metabolite, 25(oh)d, seefigure 1), healthy (see example [12,13]).']
S85-PMC4251419	PMC4251419	12/2014	S85-PMC4251419	['in the experimental Autoimmune encephalomyelitis Animal MODEL, Vitamin D supplementation in the Postnatal period delays the onset of the disease [52] but there is NO EVIDENCE that Antenatal Vitamin D supplementation has any EFFECT.']	[('INCOMPLETE_EVIDENCE', 56), ('INCOMPLETE_EVIDENCE', 163), ('SUPERFICIAL_RELATIONSHIP', 224)]	3	[('UBERON_0001442', 'skeleton of manus', 20, 'autoimmune'), ('NCBITaxon_33208', 'Metazoa', 49, 'animal'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0007567', 'parturition', 96, 'postnatal'), ('GO_0007567', 'parturition', 180, 'antenatal'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D')]	0	[' encephalomyelitis animal model,  supplementation postnatal period delays onset antenatal  supplementation effect.']
S130-PMC4251419	PMC4251419	12/2014	S130-PMC4251419	['in addition, with respect to an ability of supplemental Vitamin D to alter the course of Autoimmune diseases, there is DEBATE about the VALIDITY of biochemical OR cellular markers from Blood AS TRULY representative of disease status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 119), ('IMPORTANT_CONSIDERATION', 136), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 160), ('PROBABLE_UNDERSTANDING', 191), ('PROBABLE_UNDERSTANDING', 194)]	5	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 89, 'autoimmune'), ('UBERON_0000178', 'blood', 185, 'blood')]	0	['addition, respect ability supplemental  alter course  diseases, biochemical cellular blood representative disease status.']
S160-PMC4251419	PMC4251419	12/2014	S160-PMC4251419	['conclusion\nthe jury is STILL out on the IMPORTANCE of Vitamin D for Immune function: both for Vitamin D deficiency increasing the RISK of Autoimmune diseases and Viral infections through loss of Regulatory Adaptive Immune functions, as well as for high Vitamin D levels decreasing the risks of tuberculosis and infections with other Intracellular pathogens through upregulation of Innate Immunity.']	[('IMPORTANT_CONSIDERATION', 23), ('IMPORTANT_CONSIDERATION', 40), ('IMPORTANT_CONSIDERATION', 130)]	3	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('UBERON_0002405', 'immune system', 68, 'immune'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 138, 'autoimmune'), ('NCBITaxon_1', 'root', 162, 'viral'), ('GO_0008016', 'regulation of heart contraction', 195, 'regulatory adaptive immune'), ('UBERON_0002405', 'immune system', 215, 'immune'), ('CHEBI_27300', 'vitamin D', 253, 'vitamin D'), ('GO_0005622', 'intracellular anatomical structure', 333, 'intracellular'), ('GO_0045087', 'innate immune response', 381, 'innate immunity')]	0	['conclusion\nthe jury  immune function:   diseases viral infections loss adaptive immune functions,  levels decreasing tuberculosis infections intracellular pathogens upregulation innate immunity.']
S165-PMC4329404	PMC4329404	10/2014	S165-PMC4329404	['MODELS of Autoimmune disease have either supplemented Vitamin D-sufficient Animals and shown benefit or only compared responses in Vitamin D-deficient Animals, without a sufficient positive control group.']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('UBERON_0001442', 'skeleton of manus', 10, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 75, 'animals'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 151, 'animals')]	0	['models  disease supplemented -sufficient animals responses -deficient animals, positive group.']
S12-PMC4417995	PMC4417995	4/2015	S12-PMC4417995	['the function of Vitamin D, traditionally ASSOCIATED with calcium and Phosphate Homeostasis, IS THOUGHT TO be highly COMPLEX, and its POTENTIAL ROLES in Cardiovascular, neoplastic, and Microbial infections and Autoimmune diseases HAVE BEEN investigated in RECENT STUDIES [5].']	[('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 92), ('DIFFICULT_TASK', 116), ('INCOMPLETE_EVIDENCE', 133), ('SUPERFICIAL_RELATIONSHIP', 143), ('INCOMPLETE_EVIDENCE', 229), ('INCOMPLETE_EVIDENCE', 255)]	7	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('GO_0051320', 'S phase', 69, 'phosphate'), ('GO_0042592', 'homeostatic process', 79, 'homeostasis'), ('UBERON_0004535', 'cardiovascular system', 152, 'cardiovascular'), ('NCBITaxon_10088', 'Mus <genus>', 184, 'microbial'), ('UBERON_0001442', 'skeleton of manus', 209, 'autoimmune')]	0	['calcium phosphate homeostasis, complex, cardiovascular, neoplastic, microbial infections  diseases [5].']
S15-PMC4466139	PMC4466139	6/2015	S15-PMC4466139	['moreover, in RECENT YEARS, Vitamin D deficiency HAS BEEN CONSIDERED AS a POSSIBLE cause of several diseases, including Microbial infections, Cardiovascular and allergic diseases, cancers, type 1 diabetes, multiple sclerosis and other Autoimmune diseases [1–10].']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 48), ('IMPORTANT_CONSIDERATION', 57), ('INCOMPLETE_EVIDENCE', 57), ('PROBABLE_UNDERSTANDING', 68), ('INCOMPLETE_EVIDENCE', 73)]	6	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 119, 'microbial'), ('UBERON_0004535', 'cardiovascular system', 141, 'cardiovascular'), ('UBERON_0001442', 'skeleton of manus', 234, 'autoimmune')]	0	['moreover, years,  diseases, microbial infections, cardiovascular allergic diseases, cancers, type diabetes, sclerosis  diseases [1–10].']
S29-PMC4488777	PMC4488777	5/2015	S29-PMC4488777	['lower Vitamin D levels HAVE BEEN FOUND in many Autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, type 1 diabetes mellitus, multiple sclerosis, Inflammatory Bowel diseases, Autoimmune Thyroid diseases [6,7].']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 33)]	2	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 47, 'autoimmune'), ('UBERON_0001782', 'pigmented layer of retina', 194, 'inflammatory bowel'), ('UBERON_0001442', 'skeleton of manus', 223, 'autoimmune'), ('UBERON_0002046', 'thyroid gland', 234, 'thyroid')]	0	['lower  levels  diseases, rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, type diabetes mellitus, sclerosis, inflammatory bowel diseases,  thyroid diseases [6,7].']
S95-PMC4624803	PMC4624803	10/2015	S95-PMC4624803	['Human studies have INDICATED that Vitamin D deficiency is ASSOCIATED with an INCREASED RISK of developing many diseases and disorders, like parkinson’s disease, epilepsy, depression, multiple sclerosis, schizophrenia, autism, and Autoimmune diseases like rheumatoid arthritis and type i diabetes mellitus [18–20].']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 58), ('IMPORTANT_CONSIDERATION', 77)]	3	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Human'), ('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 230, 'autoimmune')]	0	['human  diseases disorders, parkinson’s disease, epilepsy, depression, sclerosis, schizophrenia, autism,  diseases rheumatoid arthritis type diabetes mellitus [18–20].']
S15-PMC4632418	PMC4632418	10/2015	S15-PMC4632418	['the NON-CLASSICAL functions of Vitamin D are GAINING ATTENTION for its closer ASSOCIATIONS between Vitamin D deficiency and t2dm, Heart disease, Autoimmune diseases and certain types of cancers [4,5].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 78)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('UBERON_0000948', 'heart', 130, 'heart'), ('UBERON_0001442', 'skeleton of manus', 145, 'autoimmune')]	0	['functions  closer  t2dm, disease,  diseases cancers [4,5].']
S17-PMC4764019	PMC4764019	1/2016	S17-PMC4764019	['autoimmune disorders\ntwo SERIOUS Autoimmune diseases HAVE BEEN LINKED to low Vitamin D status in early Life, type 1 diabetes mellitus (dm1) and multiple sclerosis (ms).']	[('IMPORTANT_CONSIDERATION', 25), ('INCOMPLETE_EVIDENCE', 53), ('SUPERFICIAL_RELATIONSHIP', 63)]	3	[('UBERON_0001442', 'skeleton of manus', 33, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('UBERON_0000104', 'life cycle', 103, 'life')]	0	['autoimmune disorders\ntwo  diseases  status life, type diabetes mellitus (dm1) sclerosis (ms).']
S10-PMC4934634	PMC4934634	11/2015	S10-PMC4934634	['over the past two decades, it HAS BEEN WELL ACCEPTED that Vitamin D is a pro-hormone, and suboptimal Vitamin D status HAS been increasingly LINKED to a broad range of diseases including, cancer, diabetes, Cardiovascular disease, and Autoimmune disorders.']	[('INCOMPLETE_EVIDENCE', 30), ('FUTURE_WORK', 39), ('INCOMPLETE_EVIDENCE', 44), ('PROBABLE_UNDERSTANDING', 44), ('IMPORTANT_CONSIDERATION', 118), ('SUPERFICIAL_RELATIONSHIP', 140)]	6	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 205, 'cardiovascular'), ('UBERON_0001442', 'skeleton of manus', 233, 'autoimmune')]	0	['decades,  pro-hormone,  status broad diseases including, cancer, diabetes, cardiovascular disease,  disorders.']
S80-PMC5030591	PMC5030591	9/2016	S80-PMC5030591	"['[""""caption (table-wrap): table 4\\n\\nthemes and elements relating to specific Conception and Pregnancy information for women with rheumatoid arthritis and their familiessaying : information that should be discussed by health professionals doing : actions that SHOULD BE undertaken by health professionals review of current Medications in relation to safety during Conception and Pregnancy (100%) prior to Conception and Pregnancy, review current Medication(s) and discuss:\\nmedications vary with respect to their SAFETY during Pregnancy and RISKS related to Fertility, Ovulation, Conception and Miscarriage\\nSOME Medicines used in ra care MAY have EFFECTS on Fertility, Conception and Pregnancy process, for example, regular Nsaids MAY impair fertility and ASSOCIATED RISKS with fetus\\nit is IMPORTANT to time Conceptionprovide GUIDANCE as to WHERE to obtain reliable information about SAFETY of Medicines in Pregnancywhere current Medication(s) is (are) contraindicated for Conception/Pregnancy the following SHOULD BE discussed with the patient:\\nthere are SAFE Medication options pre, during (including Delivery) and Postpregnancy (including Breast feeding)\\ntiming is IMPORTANT in RELATION to ceasing or switching of current Medications and allowing for washout periods prior to Conception\\nthere is a need for close supervision/monitoring by a rheumatologist when discontinuing current Medications prior to Pregnancy, including CONSIDERING POTENTIAL NEED for disease stabilisation on new treatment prior to Conception and Pregnancydiscuss IMPACT of ra pathology on Pregnancy and Pregnancy on ra (100%) there are DIFFERENT SCENARIOS regarding ra disease activity during Pregnancy (eg, POSSIBLE remission/low disease activity)discuss: ra-related pain management options during Pregnancyconception MAY take longer compared with women who do not have rathere is a need to balance disease Control with maternal and fetal health and safetyra MAY AFFECT Pregnancy and Pregnancy MAY AFFECT ra, and there are POSSIBLE adverse outcomes where risks are identified (eg, Prematurity)there are significant risks ASSOCIATED with active or uncontrolled ra for the mother and baby, ESPECIALLY irreversible Joint damage and functional impairmentpregnancy MAY change a patient’s health outlook in the futurethe size of the baby MAY BE smaller than women without ra and MAY also be Delivered pre-term discuss IMPORTANT elements of Preconception care RELEVANT to patient (97.1%) it is IMPORTANT to achieve optimal disease control prior to considering Pregnancy—Planning Conception is preferable after patients achieve and maintain low disease activityencourage and facilitate early discussions with all health practitioners involved in care about family planning to allow for adequate preparationthere is a CRITICAL need for a planned Pregnancy RATHER than an unplanned Pregnancyreview Prenatal nutrition, including need for dietary/vitamin supplements (ie, Folic Acid, calcium, Vitamin D, Iodine, iron)history of previous Attempts To Conceive/Pregnancies or Pregnancy-related complications (eg, Miscarriage) and other relevant patient history (such as smoking/Illicit Drug use history, family history of hereditary issues) MAY AFFECT Pregnancyundertake RELEVANT health checks such as immunisation status (eg, rubella, varicella, pertussis), Sexually Transmitted disease screening, pap test, screening for other Autoimmune disorders that MAY IMPACT on Pregnancyweight management and appropriate exercise are very IMPORTANTCONSIDER the NEED for review of diabetes or impaired Glucose tolerance if RISK factors are present (eg, on Steroid medication or overweight/obese)it is IMPORTANT to manage comorbid conditions, such as diabetes and hypertensionsome women MAY NEED to avoid Conception during a flarera disease activity MAY or MAY not improve with Pregnancy and there is a LIKELIHOOD of Postpartum flares importance of maintaining optimistic outlook and providing positive messages (97.1%) Pregnancy and Breast feeding success rates are near normal in women with mild to moderate ra nowadays (where appropriate for the patient\'s clinical status)ra is not a BARRIER to Pregnancystrategies to address anxiety, stress and depression (if relevant) are IMPORTANT, such as mindfulness meditation need for close monitoring of a patient prior to and during Pregnancy, where indicated (94.1%) it is IMPORTANCE to have a healthcare team with expertise in Autoimmune disorders for SOME women with radetermine THE NEED for high-level obstetric care during a Pregnancy (where indicated), including the need for Anaesthetic inputsome women REQUIRE closer monitoring of their Pregnancy and this is USUALLY proportional to disease activity, comorbidities and maternal historyassess the REQUIREMENTS for any extra treatment or monitoring prior to, or during, Pregnancyit is IMPORTANT to develop a Pregnancy plan, which includes different options for management of ra and support for different scenariosvaginal Delivery MAY NOT always BE POSSIBLE, depending on condition of the patient\'s Hips.""""]']"	[('FUTURE_WORK', 254), ('IMPORTANT_CONSIDERATION', 506), ('IMPORTANT_CONSIDERATION', 534), ('INCOMPLETE_EVIDENCE', 600), ('INCOMPLETE_EVIDENCE', 631), ('SUPERFICIAL_RELATIONSHIP', 640), ('INCOMPLETE_EVIDENCE', 724), ('SUPERFICIAL_RELATIONSHIP', 749), ('IMPORTANT_CONSIDERATION', 760), ('IMPORTANT_CONSIDERATION', 783), ('FUTURE_WORK', 819), ('EXPLICIT_QUESTION', 834), ('IMPORTANT_CONSIDERATION', 877), ('FUTURE_WORK', 1001), ('IMPORTANT_CONSIDERATION', 1049), ('IMPORTANT_CONSIDERATION', 1161), ('SUPERFICIAL_RELATIONSHIP', 1174), ('FUTURE_WORK', 1421), ('IMPORTANT_CONSIDERATION', 1421), ('INCOMPLETE_EVIDENCE', 1433), ('SUPERFICIAL_RELATIONSHIP', 1532), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1605), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1615), ('INCOMPLETE_EVIDENCE', 1677), ('INCOMPLETE_EVIDENCE', 1788), ('INCOMPLETE_EVIDENCE', 1929), ('SUPERFICIAL_RELATIONSHIP', 1933), ('INCOMPLETE_EVIDENCE', 1964), ('SUPERFICIAL_RELATIONSHIP', 1968), ('INCOMPLETE_EVIDENCE', 1993), ('SUPERFICIAL_RELATIONSHIP', 2091), ('IMPORTANT_CONSIDERATION', 2158), ('INCOMPLETE_EVIDENCE', 2230), ('INCOMPLETE_EVIDENCE', 2302), ('INCOMPLETE_EVIDENCE', 2343), ('IMPORTANT_CONSIDERATION', 2382), ('SUPERFICIAL_RELATIONSHIP', 2423), ('IMPORTANT_CONSIDERATION', 2457), ('IMPORTANT_CONSIDERATION', 2779), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2817), ('INCOMPLETE_EVIDENCE', 3196), ('SUPERFICIAL_RELATIONSHIP', 3200), ('IMPORTANT_CONSIDERATION', 3226), ('INCOMPLETE_EVIDENCE', 3410), ('SUPERFICIAL_RELATIONSHIP', 3414), ('IMPORTANT_CONSIDERATION', 3485), ('INCOMPLETE_EVIDENCE', 3507), ('SUPERFICIAL_RELATIONSHIP', 3568), ('IMPORTANT_CONSIDERATION', 3646), ('INCOMPLETE_EVIDENCE', 3731), ('FUTURE_WORK', 3735), ('IMPORTANT_CONSIDERATION', 3735), ('INCOMPLETE_EVIDENCE', 3794), ('INCOMPLETE_EVIDENCE', 3801), ('PROBABLE_UNDERSTANDING', 3847), ('DIFFICULT_TASK', 4131), ('IMPORTANT_CONSIDERATION', 4222), ('IMPORTANT_CONSIDERATION', 4364), ('INCOMPLETE_EVIDENCE', 4444), ('INCOMPLETE_EVIDENCE', 4472), ('IMPORTANT_CONSIDERATION', 4600), ('INCOMPLETE_EVIDENCE', 4657), ('IMPORTANT_CONSIDERATION', 4744), ('IMPORTANT_CONSIDERATION', 4831), ('INCOMPLETE_EVIDENCE', 4976), ('DIFFICULT_TASK', 4980)]	66	[('GO_0007631', 'feeding behavior', 72, 'conception ...'), ('GO_0007565', 'female pregnancy', 87, 'pregnancy'), ('CHEBI_25441', 'mycothiols', 317, 'medications'), ('GO_0007620', 'copulation', 358, 'conception'), ('GO_0007565', 'female pregnancy', 373, 'pregnancy'), ('GO_0007620', 'copulation', 399, 'conception'), ('GO_0007565', 'female pregnancy', 414, 'pregnancy'), ('CHEBI_60211', 'compound Z', 440, 'medication'), ('GO_0007565', 'female pregnancy', 520, 'pregnancy'), ('GO_0009566', 'fertilization', 551, 'fertility'), ('GO_0030728', 'ovulation', 562, 'ovulation'), ('GO_0007620', 'copulation', 573, 'conception'), ('GO_0046660', 'female sex differentiation', 588, 'miscarriage'), ('CHEBI_25179', 'melanins', 605, 'medicines'), ('GO_0009566', 'fertilization', 651, 'fertility'), ('GO_0007620', 'copulation', 662, 'conception'), ('GO_0007565', 'female pregnancy', 677, 'pregnancy'), ('CHEBI_16039', 'ITP', 717, 'NSAIDs'), ('GO_0070268', 'cornification', 801, 'conceptionProvide'), ('CHEBI_25179', 'melanins', 887, 'medicines'), ('GO_0000712', 'resolution of meiotic recombination intermediates', 900, 'pregnancyWhere'), ('CHEBI_60211', 'compound Z', 923, 'medication'), ('GO_0007620', 'copulation', 966, 'conception'), ('GO_0007565', 'female pregnancy', 977, 'pregnancy'), ('CHEBI_60211', 'compound Z', 1054, 'medication'), ('GO_0007567', 'parturition', 1096, 'delivery'), ('GO_0007565', 'female pregnancy', 1110, 'postpregnancy'), ('UBERON_0000310', 'breast', 1135, 'breast'), ('CHEBI_25441', 'mycothiols', 1218, 'medications'), ('GO_0007620', 'copulation', 1272, 'conception'), ('CHEBI_25441', 'mycothiols', 1379, 'medications'), ('GO_0007565', 'female pregnancy', 1400, 'pregnancy'), ('GO_0007620', 'copulation', 1500, 'conception'), ('GO_0006915', 'apoptotic process', 1515, 'pregnancyDiscuss'), ('GO_0007565', 'female pregnancy', 1558, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1572, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1662, 'pregnancy'), ('GO_0007602', 'phototransduction', 1768, 'pregnancyConception'), ('GO_0065007', 'biological regulation', 1877, 'control'), ('GO_0007565', 'female pregnancy', 1940, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1954, 'pregnancy'), ('GO_0007565', 'female pregnancy', 2051, 'prematurity'), ('UBERON_0004905', 'articulation', 2182, 'joint'), ('GO_0007567', 'parturition', 2355, 'delivered'), ('GO_0007565', 'female pregnancy', 2404, 'preconception'), ('GO_0007565', 'female pregnancy', 2523, 'pregnancy'), ('GO_0006260', 'DNA replication', 2533, 'planning'), ('GO_0007620', 'copulation', 2542, 'conception'), ('GO_0007565', 'female pregnancy', 2807, 'pregnancy'), ('GO_0006412', 'translation', 2842, 'pregnancyReview'), ('GO_0007565', 'female pregnancy', 2858, 'prenatal'), ('CHEBI_30751', 'formic acid', 2930, 'folic acid'), ('CHEBI_27300', 'vitamin D', 2951, 'vitamin D'), ('CHEBI_24859', 'iodine atom', 2962, 'iodine'), ('GO_0000380', 'alternative mRNA splicing, via spliceosome', 2995, 'attempts to conceive'), ('GO_0007565', 'female pregnancy', 3016, 'pregnancies'), ('GO_0007565', 'female pregnancy', 3031, 'pregnancy'), ('GO_0046660', 'female sex differentiation', 3068, 'miscarriage'), ('CHEBI_35704', 'N(2)-acetyl-L-lysine', 3133, 'illicit drug'), ('GO_0051610', 'serotonin uptake', 3207, 'pregnancyUndertake'), ('GO_0019095', 'pole plasm mitochondrial rRNA localization', 3314, 'sexually transmitted'), ('UBERON_0001442', 'skeleton of manus', 3384, 'autoimmune'), ('GO_0006412', 'translation', 3424, 'pregnancyWeight'), ('CHEBI_17234', 'glucose', 3547, 'glucose'), ('CHEBI_35341', 'steroid', 3601, 'steroid'), ('GO_0007620', 'copulation', 3749, 'conception'), ('GO_0007565', 'female pregnancy', 3822, 'pregnancy'), ('GO_0007565', 'female pregnancy', 3861, 'postpartum'), ('GO_0007565', 'female pregnancy', 3964, 'Pregnancy'), ('UBERON_0000310', 'breast', 3978, 'breast'), ('GO_0006915', 'apoptotic process', 4142, 'pregnancyStrategies'), ('GO_0007565', 'female pregnancy', 4323, 'pregnancy'), ('UBERON_0001442', 'skeleton of manus', 4419, 'autoimmune'), ('GO_0007565', 'female pregnancy', 4520, 'pregnancy'), ('CHEBI_38867', 'anaesthetic', 4572, 'anaesthetic'), ('GO_0007565', 'female pregnancy', 4635, 'pregnancy'), ('GO_0007565', 'female pregnancy', 4816, 'pregnancyIt'), ('GO_0007565', 'female pregnancy', 4854, 'pregnancy'), ('GO_0007567', 'parturition', 4967, 'delivery'), ('UBERON_0000988', 'pons', 5044, 'hips')]	0	"['[""""caption (table-wrap): table 4\\n\\nthemes elements pregnancy women rheumatoid arthritis familiessaying : professionals : professionals medications pregnancy (100%) pregnancy, medication(s) discuss:\\nmedications respect pregnancy fertility, ovulation, miscarriage\\nsome medicines ra fertility, pregnancy process, example, nsaids fertility fetus\\nit conceptionprovide obtain medicines pregnancywhere medication(s) (are) conception/pregnancy following patient:\\nthere medication pre, (including delivery) postpregnancy (including breast feeding)\\ntiming ceasing switching medications allowing washout periods conception\\nthere close supervision/monitoring rheumatologist discontinuing medications pregnancy, disease stabilisation treatment pregnancydiscuss ra pathology pregnancy pregnancy ra (100%) regarding ra disease activity pregnancy (eg, remission/low disease activity)discuss: ra-related pain pregnancyconception longer women rathere balance disease maternal fetal safetyra pregnancy pregnancy ra, outcomes (eg, prematurity)there ra mother baby, irreversible joint functional impairmentpregnancy patient’s outlook futurethe baby women ra delivered pre-term elements preconception patient (97.1%) achieve disease pregnancy—planning patients achieve maintain disease activityencourage discussions practitioners family preparationthere pregnancy pregnancyreview prenatal nutrition, dietary/vitamin supplements (ie, folic acid, vitamin d, iodine, iron)history conceive/pregnancies pregnancy-related (eg, miscarriage) patient (such smoking/illicit drug history, family hereditary issues) pregnancyundertake checks immunisation status (eg, rubella, varicella, pertussis), sexually transmitted disease screening, pap test, screening autoimmune disorders pregnancyweight exercise diabetes glucose tolerance (eg, steroid medication overweight/obese)it manage comorbid conditions, diabetes hypertensionsome women flarera disease activity pregnancy postpartum flares maintaining optimistic outlook positive (97.1%) pregnancy breast feeding rates normal women ra nowadays (where patient*s status)ra pregnancystrategies anxiety, depression (if relevant) important, mindfulness meditation close patient pregnancy, (94.1%) healthcare team ex autoimmune disorders women radetermine high-level obstetric pregnancy (where indicated), anaesthetic inputsome women closer pregnancy proportional disease activity, comorbidities maternal historyassess extra treatment to, during, pregnancyit pregnancy plan, includes ra scenariosvaginal delivery possible, condition patient*s hips.""""]']"
S80-PMC5095257	PMC5095257	11/2016	S80-PMC5095257	['one of the POSTULATED mechanisms EXPLAINING a month-of-Birth EFFECT in Autoimmune disease is the ROLE that Vitamin D deficiency MIGHT play in the pathophysiology of such diseases (31).']	[('INCOMPLETE_EVIDENCE', 11), ('PROBABLE_UNDERSTANDING', 33), ('SUPERFICIAL_RELATIONSHIP', 61), ('SUPERFICIAL_RELATIONSHIP', 97), ('INCOMPLETE_EVIDENCE', 128)]	5	[('GO_0007567', 'parturition', 55, 'birth'), ('UBERON_0001442', 'skeleton of manus', 71, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D')]	0	['one mechanisms month-of-birth  disease  play pathophysiology diseases (31).']
S50-PMC5310660	PMC5310660	1/2017	S50-PMC5310660	['Genes ASSOCIATED with many Autoimmune diseases are enriched for Vitamin D receptor-Binding Sites [19-21], SUGGESTING that the combined EFFECT of Vitamin D deficiency, Genetic variation, and exposure to other environmental agents MAY concur in the pathogenesis.']	[('SUPERFICIAL_RELATIONSHIP', 6), ('INCOMPLETE_EVIDENCE', 106), ('SUPERFICIAL_RELATIONSHIP', 135), ('INCOMPLETE_EVIDENCE', 229)]	4	[('SO_0000704', 'gene', 0, 'Genes'), ('UBERON_0001442', 'skeleton of manus', 27, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('SO_0000409', 'binding_site', 83, 'binding sites'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('SO_0000704', 'gene', 167, 'genetic')]	0	['genes  diseases enriched  receptor-binding sites [19-21], combined  deficiency, genetic variation, exposure environmental agents pathogenesis.']
S13-PMC5340372	PMC5340372	3/2017	S13-PMC5340372	['since the discovery that MOST Tissues and cells have Vitamin D receptors, there has been great INTEREST in its ROLE in the development of many diseases, such as cancer [1], Cardiovascular diseases [2], infectious diseases [3], and Autoimmune disease [4].']	[('PROBABLE_UNDERSTANDING', 25), ('IMPORTANT_CONSIDERATION', 95), ('SUPERFICIAL_RELATIONSHIP', 111)]	3	[('UBERON_0000479', 'tissue', 30, 'tissues'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 173, 'cardiovascular'), ('UBERON_0001442', 'skeleton of manus', 231, 'autoimmune')]	0	['since tissues cells  receptors, diseases, cancer [1], cardiovascular diseases [2], infectious diseases [3],  disease [4].']
S6-PMC5405075	PMC5405075	4/2017	S6-PMC5405075	['introduction\nepidemiological and experimental data on health IMPACT of “Multitasking” Vitamin D SUPPORT a PROTECTIVE EFFECT of Vitamin D over diseases such as cancer, Cardiovascular, Autoimmune, dementia, and diabetes (1,2).']	[('SUPERFICIAL_RELATIONSHIP', 61), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 106), ('SUPERFICIAL_RELATIONSHIP', 117)]	4	[('GO_0007618', 'mating', 72, 'multitasking'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 167, 'cardiovascular'), ('UBERON_0001442', 'skeleton of manus', 183, 'autoimmune')]	0	['introduction\nepidemiological “multitasking”   diseases cancer, cardiovascular, dementia, diabetes (1,2).']
S30-PMC5405075	PMC5405075	4/2017	S30-PMC5405075	['Gestational Vitamin D has now been LINKED to a variety of diseases such as osteoporosis, Autoimmune disorders, altered Brain Development and Adult mental health, Food allergies, and asthma (17,29,31–33).']	[('SUPERFICIAL_RELATIONSHIP', 35)]	1	[('GO_0007565', 'female pregnancy', 0, 'Gestational'), ('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 89, 'autoimmune'), ('GO_0007420', 'brain development', 119, 'brain development'), ('UBERON_0000955', 'brain', 119, 'brain'), ('UBERON_0007023', 'adult organism', 141, 'adult'), ('CHEBI_33290', 'food', 162, 'food')]	0	['gestational  diseases osteoporosis,  disorders, altered brain adult mental health, food allergies, asthma (17,29,31–33).']
S0-PMC5685050	PMC5685050	10/2014	S0-PMC5685050	['vitamin D deficiency in thailand☆\nvitamin D deficiency has received INCREASED ATTENTION over the past several years since Vitamin D MAY play an IMPORTANT ROLE not ONLY in bone Metabolism but also in a variety of non-Skeletal diseases such as diabetes mellitus, Autoimmune diseases, infectious diseases, Cardiovascular diseases and cancer1,2,3.']	[('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 132), ('IMPORTANT_CONSIDERATION', 144), ('SUPERFICIAL_RELATIONSHIP', 154), ('INCOMPLETE_EVIDENCE', 163)]	5	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 8, 'D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 42, 'D'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('GO_0008152', 'metabolic process', 176, 'metabolism'), ('UBERON_0004288', 'skeleton', 216, 'skeletal'), ('UBERON_0001442', 'skeleton of manus', 261, 'autoimmune'), ('UBERON_0004535', 'cardiovascular system', 303, 'cardiovascular')]	0	['vitamin thailand☆\nvitamin received  play bone metabolism non-skeletal diseases diabetes mellitus,  diseases, infectious diseases, cardiovascular diseases cancer1,2,3.']
S2-PMC5941617	PMC5941617	5/2018	S2-PMC5941617	['indeed, RECENT DATA SUGGEST a POSSIBLE ROLE of Vitamin D in the pathogenesis of several pathological conditions, including infectious, allergic and Autoimmune diseases.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 39)]	4	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 148, 'autoimmune')]	0	['indeed,  pathogenesis pathological conditions, infectious, allergic  diseases.']
S7-PMC5941617	PMC5941617	5/2018	S7-PMC5941617	['besides these classic Skeletal actions, RECENT STUDIES have DEMONSTRATED that Vitamin D exerts OTHER significant Extraskeletal actions, with a POSSIBLE ROLE in the pathogenesis of several pathological conditions, including infectious and Autoimmune diseases [1].']	[('INCOMPLETE_EVIDENCE', 40), ('INCOMPLETE_EVIDENCE', 60), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('INCOMPLETE_EVIDENCE', 143), ('SUPERFICIAL_RELATIONSHIP', 152)]	5	[('UBERON_0004288', 'skeleton', 22, 'skeletal'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 113, 'extraskeletal'), ('UBERON_0001442', 'skeleton of manus', 238, 'autoimmune')]	0	['besides skeletal actions,  exerts extraskeletal actions, pathogenesis pathological conditions, infectious  diseases [1].']
S1-PMC5956785	PMC5956785	5/2018	S1-PMC5956785	['WHILE the ROLES of Vitamin D in OTHER Autoimmune diseases HAVE BEEN investigated, less is known about the ROLE of Vitamin D in chronic childhood arthritis.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('INCOMPLETE_EVIDENCE', 58), ('SUPERFICIAL_RELATIONSHIP', 106)]	5	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 38, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]	0	['  diseases investigated,  chronic childhood arthritis.']
S15-PMC5956785	PMC5956785	5/2018	S15-PMC5956785	['AS an Immune and inflammatory Mediator, Vitamin D is IMPLICATED in the pathogenesis of Autoimmune diseases including, as examples, multiple sclerosis, type 1 diabetes, rheumatoid arthritis, crohn’s disease, and chronic childhood arthritis [4–6].']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 53)]	2	[('UBERON_0002405', 'immune system', 6, 'immune'), ('CHEBI_35222', 'inhibitor', 30, 'mediator'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 87, 'autoimmune')]	0	['immune inflammatory mediator,  pathogenesis  diseases including, examples, sclerosis, type diabetes, rheumatoid arthritis, crohn’s disease, chronic childhood arthritis [4–6].']
S192-PMC5956785	PMC5956785	5/2018	S192-PMC5956785	['to date, the EVIDENCE TO SUPPORT a RELATIONSHIP between Vitamin D and disease activity with Autoimmune diseases in Humans is CORRELATIVE and not causative [71].']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 35), ('SUPERFICIAL_RELATIONSHIP', 125)]	4	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 92, 'autoimmune'), ('NCBITaxon_9606', 'Homo sapiens', 115, 'humans')]	0	['date,  disease activity  diseases humans causative [71].']
S207-PMC5956785	PMC5956785	5/2018	S207-PMC5956785	['it HAS BEEN THEORIZED that there MAY BE an increased utilization of Vitamin D during active inflammation, POSSIBLY caused by \\the presence of Vitamin D receptor polymorphisms in patients with Autoimmune diseases [6,72].']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('INCOMPLETE_EVIDENCE', 12), ('PROBABLE_UNDERSTANDING', 12), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 106)]	6	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 192, 'autoimmune')]	0	['utilization  inflammation, \\the presence  receptor polymorphisms patients  diseases [6,72].']
S239-PMC5956785	PMC5956785	5/2018	S239-PMC5956785	['exploring elements of Vitamin D status that MAY have a ROLE in disease development such as early Life and Gestational Vitamin D status as well as Genes in the Vitamin D pathway will help TO CLARIFY the ROLE of Vitamin D.\nseason of Birth HAS BEEN SUGGESTED to have an IMPACT on the risk of developing a number of Autoimmune diseases such as multiple sclerosis, type 1 diabetes and celiac disease [78].']	[('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 55), ('FUTURE_WORK', 187), ('SUPERFICIAL_RELATIONSHIP', 202), ('INCOMPLETE_EVIDENCE', 237), ('SUPERFICIAL_RELATIONSHIP', 267)]	6	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0000104', 'life cycle', 97, 'life'), ('GO_0007565', 'female pregnancy', 106, 'gestational'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('SO_0000704', 'gene', 146, 'genes'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin D'), ('GO_0007567', 'parturition', 231, 'birth'), ('UBERON_0001442', 'skeleton of manus', 312, 'autoimmune')]	0	['exploring elements  status disease life gestational  status genes  .\nseason birth  diseases sclerosis, type diabetes celiac disease [78].']
S279-PMC5956785	PMC5956785	5/2018	S279-PMC5956785	['thus far, we KNOW that there is a ROLE for Vitamin D in the inflammatory pathways, a high prevalence of 25(Oh)D insufficiency among children with jia, and an established LINK of Vitamin D with other Autoimmune diseases.']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 34), ('SUPERFICIAL_RELATIONSHIP', 170)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 104, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 199, 'autoimmune')]	0	['thus far,  inflammatory pathways, 25(oh)d among children jia,   diseases.']
